CINECA IRIS Institutional Research Information System

Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies

Scagliotti, Giorgio V.
Last
2017-01-01
2017
CLINICAL LUNG CANCER
18
5
489
496
http://www.journals.elsevier.com/clinical-lung-cancer/
Adverse events; Cross-trial analysis; First-line treatment; Post-hoc analysis; Treatment duration; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fatigue; Humans; Lung Neoplasms; Maintenance Chemotherapy; Nausea; Neutropenia; Pemetrexed; Remission Induction; Retrospective Studies; Vomiting; Oncology; Pulmonary and Respiratory Medicine; Cancer Research
Langer, Corey J.; Paz-Ares, Luis G.; Wozniak, Antoinette J.; Gridelli, Cesare; de Marinis, Filippo; Pujol, Jean-Louis; San Antonio, Belen; Chen, Jian; Liu, Jingyi; Oton, Ana B.; Visseren-Grul, Carla; Scagliotti, Giorgio V.*
03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC_ Retrospective Analyses From 2 Phase III Studies.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.09 MB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
1.09 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1680276
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact